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Abstract Resveratrol (3,40,5-trihydroxystilbene) is a
phytochemical believed to be partly responsible for the
cardioprotective effects of red wine due to its numerous
biological activities. Here, we studied biochemical path-
ways underlying peroxynitrite-mediated apoptosis in
endothelial cells and potential mechanisms responsible for
resveratrol cytoprotective action. Peroxynitrite triggered
endothelial cell apoptosis through caspases-8, -9 and -3
activation implying both mitochondrial and death receptor
apoptotic pathways. Resveratrol was able to prevent per-
oxynitrite-induced caspases-3 and -9 activation, but not
caspase-8 activation. Additionally, peroxynitrite increased
intracellular levels of Bax without affecting those of Bcl-2,
increasing consequently the Bax/Bcl-2 ratio. This ratio
decreased when cells where pre-incubated with 10 and
50 lM resveratrol, mainly due to resveratrol ability per se
to increase Bcl-2 intracellular levels without affecting Bax
intracellular levels. These results propose an additional
mechanism whereby resveratrol may exert its cardiopro-
tective effects and suggest a key role for Bcl-2 in the
resveratrol anti-apoptotic action, especially in disrupting
peroxynitrite-triggered mitochondrial pathway.
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Abbreviations
NOS Nitric oxide synthase
PARP-1 Poly(ADP-ribose) polymerase-1
BAEC Bovine aortic endothelial cells
TMRM Tetramethylrhodamine methyl ester
MOM Mitochondrial outer membrane
PTP Permeability transition pore
MPT Mitochondrial permeability transition
GSH Glutathione
ANT Mitochondrial inner membrane protein adenine
nucleotide translocase
CREB cAMP response element-binding protein
Introduction
Atherosclerosis is a multifaceted disorder where endothe-
lial dysfunction plays a key role [1]. Endothelium is
constituted by a single monolayer of endothelial cells that
acts as a selective and permeable barrier and regulates
multiple functions such as vascular tone, thrombosis,
inflammation, platelet aggregation and vascular remodel-
ling [2]. Therefore, any damage or stress in endothelial
cells will disturb endothelium functions leading to its
dysfunction. On the other hand, apoptosis of arterial
endothelial cells is a prominent feature of atherosclerotic
plaques which contributes to its instability and amplifies
endothelial dysfunction, and subsequently atherosclerosis
by inducing a dramatic inflammatory response [3]. Several
evidences in literature point to the association between
oxidative, nitrosative/nitrative stress and endothelial dys-
function, as atherosclerotic lesions occur predominantly in
areas with disturbed blood flow where an increase in
superoxide anion (O2
•-) generation and a decrease in nitric
oxide (NO) are observed [4]. This is of major importance
since an overproduction of O2
•- by several enzymes, such
as NAD(P)H oxidase, xanthine oxidase and uncoupled
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NOS, will counteract beneficial effects of NO on the vas-
culature by oxidizing it to the highly reactive species
peroxynitrite (ONOO-) [5]. In fact, 3-nitrotyrosine, a bio-
logical marker of peroxynitrite generation, increases in
human atherosclerotic tissue [6, 7]. Peroxynitrite is a
powerful oxidant and a nitrating species able to react with
and to modify a wide range of biomolecules, including
DNA, proteins and lipids, leading to the dysfunction of
critical cellular processes, disruption of cell signalling
pathways, and the induction of cell death through both
apoptosis and necrosis [8–10].
In vitro studies have shown that peroxynitrite could
induce endothelial cell death either by an apoptotic or
necrotic programmed pathway, depending on peroxynitrite
cell exposure conditions and concentrations. Szabo´ and
collaborators have reported a non passive necrotic cell
death initiated by DNA oxidative injury and subsequent
activation of the nuclear enzyme poly (ADP-ribose) poly-
merase-1 followed by depletion of NAD+ and ATP cellular
pools [11, 12]. On the contrary, we and others have
observed morphological changes in endothelial cells upon
exposure to peroxynitrite consistent with apoptosis, but the
apoptotic machinery remains poorly understood [13, 14].
Resveratrol (3,40,5-trihydroxystilbene), a phytoalexin
synthesized in several plants has been a focus of atten-
tion in the cardiovascular research field, since it has been
detected in red wine and pointed to be responsible for
the cardioprotective effects observed in moderate wine
drinkers [15]. Afterwards, research has reported a myriad
of resveratrol biological activities, including antioxidant,
anti-inflammatory, anti-platelet aggregation and anti-
proliferative activities which improve not only endo-
thelial function but also the cardiovascular system in
general, supporting a role for resveratrol as a cardio-
protective agent [16–19]. Previously, we have shown
that resveratrol, at a high concentration (50 lM), was
able to prevent endothelial cell death through an indirect
antioxidant activity by increasing the intracellular glu-
tathione (GSH) pools [14]. However, other cellular
mechanisms should account for the cytoprotective
effects of resveratrol because at a low concentration
(10 lM), it was able to counteract peroxynitrite delete-
rious effects on endothelial cells without increasing the
cellular glutathione concentration. So, in this work, we
aimed to investigate biochemical pathways underlying
peroxynitrite-induced apoptosis and to explore new res-
veratrol cytoprotective mechanisms against cell injury
elicited by peroxynitrite.
The data reported in this study indicate that peroxyni-
trite induces bovine aortic endothelial cells (BAEC)
apoptosis by triggering both mitochondrial and death
receptor pathway and show, for the first time, that resve-
ratrol prevents peroxynitrite cell deleterious effects by
disrupting the mitochondrial apoptotic pathway most likely
via increase in the anti-apoptotic Bcl-2 protein levels.
Materials and methods
Materials
General laboratory chemicals and some specific ones,
namely, collagenase, gelatin, streptomycin/penicillin,
MTT, Hoechst 33258, 406-diamidino-2-phenylindole
(DAPI) and protease inhibitor cocktail were obtained from
Sigma Chemicals (St. Louis, MO, USA). For cell culture,
Dulbecco’s modified Eagle’s medium (DMEM), trypsin
0.25%, fungizone, fetal bovine serum (FBS) and phos-
phate-buffered saline (PBS) pH 7.4, were purchased from
Gibco-Invitrogen. Resveratrol was from Extrasynthe`se
(Genay, France). Caspases substrates DEVD-7-AMC,
IEPD-7-AMC and LEDH-7-AFC were purchased from
Bachem (Bubendorf, Switzerland). Primary specific mouse
monoclonal antibody to Bax and anti-mouse IgG secondary
antibody were obtained from Abcam (Cambridge, UK);
primary specific mouse monoclonal antibody to Bcl-2 was
purchased from Santa Cruz Biotechnology (Santa Cruz,
CA, USA), primary specific mouse monoclonal antibody to
b-actin was purchase from Sigma (St. Louis, MO, USA).
Primary cultures of bovine aortic endothelial cells
Bovine aortic endothelial cells were isolated from thoracic
aorta after digestion with collagenase (2 mg/ml). Subse-
quently, cells were plated on gelatin-coated tissue culture
plastic and maintained in DMEM supplemented with 10%
heat inactivated fetal bovine serum, penicillin (100 U/ml),
streptomycin (100 lg/ml) and fungizone (50 ng/ml) at
37C under an humidified atmosphere of 5% CO2. Endo-
thelial cells were identified by their cobblestone
morphology and uptake of fluorescently labelled acetylated
LDL. Cells were subcultured at confluences and used
between the fourth and the seventh passage. Prior to the
experiments, cells at 80% of confluence were starved in
serum-free medium for 24 h.
Peroxynitrite synthesis
Peroxynitrite was synthesized by using a quenched flow
reactor, as previously described [20]. Briefly, an aqueous
solution of 0.6 M NaNO2 was mixed rapidly with an equal
volume of 0.7 M H2O2 containing 0.6 M HCl and imme-
diately quenched with the same volume of 1.5 M NaOH.
The solution was then frozen at -20C for approximately
24 h. At this temperature, peroxynitrite concentrates into a
dark yellow top layer (freeze fractionation), which was
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removed and passed through a short column of MnO2 for
residual H2O2 remotion according to Uppu and Pryor [21].
Then, it was stored at -80C under N2 atmosphere. Before
use, ONOO- was always quantified from the absorbance at
302 nm in 1 N NaOH (e = 1,670 cm-1M-1).
Cell treatment
Cell death was triggered by an oxidative stress induced by
peroxynitrite. For this purpose, cells were washed once
with PBS and equilibrated with PBS pH 7.4 for 5 min.
Subsequently, 500 lM ONOO- (final concentration), pre-
viously diluted in 10 mM NaOH to the required
concentration, was delivered as a single bolus against one
side of the dish while rapidly swirling the medium to
ensure optimal exposure of the cells to ONOO- before
decomposition. Cells were exposed to ONOO- for 10 min,
after which they were washed and replaced in culture
medium for the indicated times that could reach 6 h
maximum. No pH shift was observed during treatment with
ONOO-. Peroxynitrite-induced oxidative stress was pre-
formed rather in PBS than DMEM in order to avoid
interfering reactions of ONOO- with media constituents.
Same volumes of 10 mM NaOH (vehicle control) or
decomposed ONOO- (ONOO- was decomposed in PBS)
were used as controls.
When required, cells were pre-incubated with resvera-
trol for 14 h. At the end of this time, cells were washed and
incubated with ONOO- as described above. In these con-
ditions resveratrol was not present in the incubation
medium during and after ONOO- treatment.
Cell viability assay
Cell viability was evaluated by the MTT test [22]. At the
indicated times cells were washed twice with PBS and
subsequently incubated with MTT (5 mg/ml in PBS) for
2 h in the dark at 37C. Then, the MTT in each well was
taken out carefully and formazan crystals were redissolved
in DMSO. Absorbance of this solution was read at 530 nm
in a Perkin–Elmer spectrophotometer. Results were
expressed as percentage of MTT reduction, assuming that
the absorbance of control cells was 100%.
Nuclear morphology by fluorescent staining
Cells were fixed with 4% (w/v) paraformaldehyde in
phosphate buffered saline (PBS) (pH 7.4) for 15 min at
room temperature and subsequently stained with Hoechst
dye 33258 (5 lg/ml) for 15 min, washed with PBS and
mounted by using PBS/glycerol (3:1, v/v). Then, cells were
examined by fluorescence microscopy, with a Nikon fluo-
rescence microscope. Stained nuclei were scored according
to the condensation and staining characteristics of chro-
matin. Apoptotic nuclei were identified by condensed
chromatin and nuclear fragmentation and were counted in
at least six random microscopic fields (4009) per sample.
Only cells that remained attached to the plates were
observed. Mean values were expressed as the percentage of
apoptotic nuclei.
Quantification of DNA fragmentation
DNA fragmentation was evaluated as previously described
by McConkey et al. [23]. In brief, cells were recovered,
ressuspended in ice-cold lysis buffer [5 mM Tris pH 8.0,
0.5% (v/v) Triton X-100, 20 mM EDTA] for 15 min and
ultracentifuged for 20 min at 27,000g to separate intact
chromatin (pellet) from DNA cleavage products (superna-
tant). The pellet ressuspended in 1 ml of 10 mM Tris–HCl,
pH 8.0 buffer containing 1 mM EDTA and the supernatant
were assayed for DNA content by the fluorimetric DAPI
procedure according to Kapuscinski and Skooczylas [24].
Mean values of DNA fragmentation were expressed as the
percentage of total DNA.
Caspase activity assays
Caspase activation was evaluated in cytosolic protein
extracts. Briefly, at the end of the incubation times, cells
were recovered and ressuspended in ice-cold cell lysis
buffer [25 mM HEPES pH 7.4, 0.1% (w/v) CHAPS,
1 mM Na-EDTA, 1 mM Na-EGTA, 2 mM MgCl2,
100 lM PMSF, 2 mM DTT, 1/100 cocktail protease
inhibitors (v/v)] for 20 min. Subsequently, cells were
frozen/thawed five times (liquid nitrogen/37C) and cen-
trifuged at 16,000g for 10 min at 4C. The supernatant
was then collected and stored at -80C. Protein con-
centration was determined by using the Bio-Rad protein
assay kit according to the manufacture’s specifications
(Bio-Rad, USA). The enzymatic caspases activities were
determined by using substrates containing specific cleav-
age sites, linked to a fluorochrome. Equal amounts of
protein (20–25 lg) were incubated in an assay buffer
[HEPES pH 7.4, 10% (w/v) sucrose, 0.1% (w/v) CHAPS,
10 mM DTT] with 100 lM of fluorogenic peptide sub-
strates, DEVD-AMC (caspase-3 activity) IEPD-AMC
(caspase-8 activity) and LEDH-AFC (caspase-9 activity),
for 2 h at 37C. Subsequently, release of AMC or AFC
was determined by fluorescence measurement in a Per-
kin–Elmer LS50 spectrometer at an kexc = 390 nm and
kem = 475 (slits with 5 nm) for AMC, and
kexc = 395 nm and kem = 495 nm (slits with 5 nm) for
AFC. Caspases activities were calculated as the increase
above the control for equal protein loaded.
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Measurement of mitochondrial membrane potential
Cells were incubated with 500 nM tetramethylrhodamine
methyl ester (TMRM) 30 min before the end of the
experiments [25]. Subsequently, cells were washed, har-
vested and ressuspended in DMEM without phenol red and
fluorescence intensity was measured in a Perkin–Elmer
LS50 spectrometer at an kexc = 550 nm and
kem = 572 nm (slits with 10 nm). Under these conditions
there was no evidence of TMRM cytotoxicity and TMRM
was used in a non-quenched mode as observed by the
absence of increase in fluorescence intensity after addition
of FCCP to cells suspension in the cuvette. To confirm the
measurement of mitochondrial membrane potential under
these conditions, cells were pre-incubated with 2 lM
FCCP for 10 min and as expected a decrease in fluores-
cence intensity was observed. The results were normalized
to the control fluorescence intensity using the same number
of cells (1.5 9 106/ml).
Immunoblot
Total protein cell extracts were obtained after cell sus-
pension lysis in an ice-cold lysis buffer [50 mM Hepes
pH 7.4, 150 mM NaCl, 2 mM EDTA, 10% (w/v)
glycerol, 0.5% (w/v) sodium deoxycholate, 1% (v/v)
Triton X-100, 1 mM PMSF, 1/100 (v/v) proteases
cocktail inhibitor] for 20 min. Lysates were subse-
quently centrifuged at 16,000g for 10 min at 4C and
supernatants were then collected and stored at -80C.
Protein concentration was determined by using the Bio-
Rad protein assay kit, according to the manufacturer’s
specifications. Equal amount of proteins (25–40 lg)
were analyzed by electrophoresis on a 12 or 15% SDS-
polyacrylamide gel and were blotted to polyvinylidene
difluoride (PVDF) membranes (Amersham, Bucking-
hamshire, UK) for 2 h at 200 mA. To avoid non-specific
binding, membranes were blocked for 1 h at room
temperature with 5% (w/v) non-fat dried milk in TBS-T
buffer [25 mM Tris–HCl pH 7.6, 150 mM NaCl, 0.1%
(v/v) Tween 20]. Membranes were then incubated
overnight at 4C with primary mouse monoclonal anti-
Bax (dilution 1:10,000) and anti-Bcl-2 (dilution 1:300)
antibodies. After five washings with TBS-T, membranes
were incubated with phosphatase alkaline-labelled sec-
ondary antibody anti-mouse (dilution 1:20,000) for 1 h
at room temperature. Membranes were washed again
five times with TBS-T and transferred proteins were
incubated with enhanced chemifluorescence reagent
(Amersham, UK), according to the manufacturer
instruction and visualized by the VersaDoc Imaging
System (BioRad, He´rcules, CA, USA). b-Actin was used
as a control for protein loading.
Statistical analysis
All data were expressed as mean ± SEM of at least three
independent assays, each one in duplicate. Significance
between groups was assessed by one-way analysis of var-
iance (ANOVA) followed by Tukey’s or Dunnet’s (time
course assays) post hoc tests. A value of P lower than 0.05
was considered statistically significant.
Results
Resveratrol prevented caspase-3 and -9 but not
caspase-8 activation induced by peroxynitrite
It has been well established that at the biochemical level,
apoptosis may be mediated through activation of initiator
and effector caspases, namely caspases-8 and -9, and cas-
pase-3, respectively [26]. Thus, we investigated the
putative role of caspases in resveratrol protective effects
against peroxynitrite-mediated cell death.
Nuclear morphological changes of BAEC assessed after
nuclear staining with Hoechst and DNA fragmentation
assessed by the DAPI quantitative procedure corroborated
our previous results that a 14 h pre-incubation of BAEC
with 10 or 50 lM resveratrol rescued cells from apoptosis
induced by 500 lM peroxynitrite (Fig. 1a). Indeed, the
significant level of apoptosis (about 25%) observed 6 h
after cells treatment with 500 lM peroxynitrite was effi-
ciently decreased by resveratrol, in a concentration-
dependent manner. Of note, resveratrol was not present in
the medium during or after peroxynitrite-treatment and
none of the tested concentrations was cytotoxic to endo-
thelial cells up to 48 h as indicated by the MTT test
(Fig. 1b).
Subsequently, we investigated the biochemical pathways
underlying peroxynitrite-induced apoptosis by evaluating
the time courses of caspases-3, -8 and -9 activation. At
shorter post-stimulation times (0–1 h), peroxynitrite
reduced, yet in a non-significant way, all tested caspases
activities to about half the control activity (Fig. 2). How-
ever, this initial caspases inactivation by peroxynitrite was
followed by a significant increase in a time dependent-
manner. Increases of about 2.3 times those of controls in
caspases-3 (P \ 0.05) and -8 (P \ 0.01) activities and of
about 2-fold in caspase-9 (P \ 0.05) activity were observed
3 h after peroxynitrite-treatment. Throughout the time
course, caspases activities increased significantly reaching
values about 3.8-fold (P \ 0.01), 3.1-fold (P \ 0.01) and
2.4-fold (P \ 0.01) higher than control for caspases-3, -8
and -9 respectively, 6 h after peroxynitrite-treatment. Once
established the involvement of caspases-3, -8 and -9 in
peroxynitrite-mediated BAEC apoptosis we investigated
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whether resveratrol could modulate or not such caspases
activation. Resveratrol inhibited peroxynitrite-induced
caspase-3 activity, in a concentration-dependent manner
(Fig. 3a). Whereas 10 lM resveratrol reduced by about
32% the 4.6-fold-increase in caspase-3 activity observed
3 h after peroxynitrite treatment, a significantly higher
reduction (51%) was achieved in cells pre-treated with
50 lM resveratrol. In contrast, none of the tested resveratrol
concentrations prevented significantly the 3.6-fold-increase
in caspase-8 activity 3 h after peroxynitrite treatment
(Fig. 3b). The lowest tested resveratrol concentration
exhibited no counteracting effects on peroxynitrite-induced
caspase-8 activity and although, the highest resveratrol
concentration tested decreased it, such decrease is not sta-
tistically significant. Finally, both resveratrol
concentrations under study thwarted efficiently caspase-9
activity triggered by peroxynitrite, as shown in Fig. 3c. The
2.8-fold-increase in caspase-9 activity, observed 3 h after
cells’ treatment with peroxynitrite was reduced by 34% or
by 52% after pre-incubating cells with 10 or 50 lM res-
veratrol, respectively. As caspase-9 and caspase-8 are well-
known initiator caspases of the mitochondrial and death
receptor apoptotic pathways, respectively, these results
suggest that resveratrol inhibits peroxynitrite-induced
endothelial cell apoptosis, preferentially by disrupting the
mitochondrial apoptotic pathway than the death receptor
pathway triggered by peroxynitrite [27].
Resveratrol did not prevent mitochondrial membrane
potential dissipation elicited by peroxynitrite
Mitochondrial outer membrane (MOM) permeabilization
and subsequent release of soluble intermembrane space
proteins, such as cytochrome c, into the cytosol where it is
responsible for caspase-9 activation, are key events in the
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Fig. 2 Apoptosis induced by peroxynitrite is mediated by caspases-3,
-8 and -9. Confluent BAEC were treated with peroxynitrite as
described in the legend of Fig. 1 and caspases activities were
quantified at different times (0–360 min) after cells treatment.
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apoptotic mitochondrial pathway [28]. One of the mecha-
nisms recognized to contribute to MOM permeabilization
is the mitochondrial inner membrane transitory permeabi-
lization through permeability transition pore (PTP) opening
[29]. Therefore, we evaluated peroxynitrite effects on
endothelial cells’ mitochondrial membrane potential. Per-
oxynitrite elicited a significant decrease in mitochondrial
membrane potential that in our model reached a maximum
of about 60%, 1 h after cells’ treatment and the decrease
remained stable until the end of the time course study (6 h)
(Fig. 4). Then, we investigated resveratrol effects on such
induced mitochondrial membrane potential dissipation.
None of the resveratrol concentrations tested protected
cells from peroxynitrite-promoted mitochondrial mem-
brane potential dissipation (Fig. 5), suggesting that the
protective effects of resveratrol at the mitochondria level
do not occur by resveratrol interference with the PTP, but
preferentially through another mechanism. Resveratrol per
se has no effect on the mitochondrial membrane potential
(data not shown).
Resveratrol increased Bcl-2 protein intracellular levels
reducing the peroxynitrite-induced Bax/Bcl-2 ratio
increase
Alternatively to the PTP, it has been proposed that Bcl-2
family proteins, important regulators of apoptosis in
mammalian cells, are implicated in the MOM permeabili-
zation [30]. Bcl-2 family proteins are divided into anti-
apoptotic proteins (Bcl-2, Bcl-XL, etc.) and pro-apoptotic
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sipation. Mitochondrial membrane potential was measured at
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proteins (Bax, Bak, etc.) that have been demonstrated to
display opposite activities in mitochondria. Consequently,
the balance between pro- and anti-apoptotic proteins is
vital for the control of cell survival. Thus, we investigated
if peroxynitrite would be able to modify the intracellular
levels of Bcl-2 family members, namely, Bax and Bcl-2.
As shown in Fig. 6a, 30 min after cells treatment with
peroxynitrite, a 2.1-fold increase in Bax protein intracel-
lular levels was observed. This increase reached a maximal
value 1 h post-stimulation time but was not sustained
during the entire experiment time course. After 1 h, Bax
protein levels decreased to values relatively constants up to
the end of the experiment. Conversely, Bcl-2 protein levels
were not significantly affected by peroxynitrite throughout
the time course study, indicating that this species might
initiate endothelial cell death by varying the balance
between Bax and Bcl-2 (Fig. 6b). In fact, an increase in
Bax levels without changes in Bcl-2 levels leads to a raise
in Bax/Bcl-2 ratio, disrupting the intracellular balance
between pro-apoptotic and anti-apoptotic proteins. Since,
Bax and Bcl-2 may be key elements in peroxynitrite-
induced apoptosis, we explored resveratrol ability to
modulate intracellular levels of these proteins and conse-
quently to hamper peroxynitrite effects.
Resveratrol per se did not affect intracellular levels of
Bax, but and unexpectedly, it exhibited a tendency to
reduce, although in a non significant mode, the peroxynitrite-
induced increase in Bax intracellular levels (Fig. 7a).
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as mean ± SEM arbitrary units of at least 4 independent experiments.
*P \ 0.05 versus control (C), **P \ 0.01 versus C
c
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On the other hand, resveratrol per se induced a significant
and dose-dependent increase in Bcl-2 intracellular levels.
Indeed, increases of 1.44 and 1.78-fold in Bcl-2 intracellular
levels were reached in the presence of 10 and 50 lM res-
veratrol, respectively (Fig. 7b). Moreover, Bcl-2 cellular
levels also increased up to 1.38-fold in cells pretreated with
10 or 50 lM resveratrol for 14 h and subsequently stimu-
lated with peroxynitrite (Fig. 7b). Therefore, as shown in
Fig. 7c, Bax/Bcl-2 ratio increased up to 2-fold, 1 h after cells
peroxynitrite treatment. This effect was completely abol-
ished by both resveratrol concentrations tested, probably, as
a consequence of the decrease in Bax/Bcl-2 ratio that
occurred in the presence of resveratrol alone (Fig. 7c).
Altogether, these results suggest that both resveratrol con-
centrations tested may interfere with the mitochondrial
apoptotic pathway triggered by peroxynitrite via modulation
of intracellular levels of Bcl-2 family proteins.
Discussion
The biochemical mechanisms underlying peroxynitrite-
mediated apoptosis and cytoprotection afforded by
resveratrol are not yet fully understood. We have previ-
ously reported that resveratrol prevents cell death triggered
by peroxynitrite by up-regulating glutathione intracellular
levels [14]. Now, we provide valuable new insights into the
biochemical cytoprotective mechanisms for resveratrol. In
fact, the results presented in this study point out bio-
chemical pathways underlying apoptosis triggered by
peroxynitrite in endothelial cells and show that resveratrol
inhibits the mitochondrial apoptotic pathway.
A growing body of evidences has demonstrated that
depending on the cell type and concentration used, per-
oxynitrite elicits different patterns of cell death, such as
caspases-dependent or -independent apoptosis and necrosis
[31–33]. Our data on caspases activation reported here
support, for the first time, an apoptotic pathway for per-
oxynitrite toxicity in endothelial cells. Caspases are key
elements of the machinery implicated in apoptosis, and can
be activated extrinsically through death receptors or
intrinsically through apoptogenic factors released from
mitochondria [27]. Caspases-8 and -9, initiator caspases of
the death receptors and of the mitochondrial pathway,
respectively, are able to activate downstream effector
caspases, like caspase-3 [26]. The activation of all three
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Fig. 7 Resveratrol increases
Bcl-2 intracellular levels,
reducing the peroxynitrite-
induced Bax/Bcl-2 ratio
increase. Total proteins were
extracted from cells incubated
with 10 and 50 lM resveratrol
for 14 h with no further
treatment or post-treated with
500 lM peroxynitrite for
10 min, as described in the
legend of Fig. 1 and maintained
for 1 h in serum-free medium at
37C. Total protein extracts
were then analyzed as described
in legend of Fig. 6.
Representative blots and
densitometric quantifications of
(a) Bax and (b) Bcl-2 and
additionally (c) Bax/Bcl ratio,
of at least four independent
experiments are shown. Results
are normalized to endogenous
b-actin and expressed as
mean ± SEM arbitrary units of
at least 4 independent
experiments. *P \ 0.05 versus
control (C), **P \ 0.01 versus
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caspases after treatment of the cells with peroxynitrite,
observed in this study, indicates that both death receptor
and mitochondrial pathways are triggered by such reactive
species. In fact, caspases activation is only observed after
2 h post-stimulation time, i.e., when peroxynitrite is no
longer present, and increases until the end of the experi-
ment. On the contrary, for shorter post-stimulation times,
we observed caspases inactivation, probably due to a direct
reaction between the oxidant and the Cys residue present in
the active site of the enzymes, since peroxynitrite reaction
with thiol groups is one of the fastest and most important
reactions described for peroxynitrite [34].
Mitochondrial outer membrane (MOM) permeabiliza-
tion is an obligatory event for the release of apoptogenic
factors, including cytochrome c that, once in the cytosol,
binds to Apaf-1 leading to the apoptosome building, a
platform that in turn recruits and activates pro-caspase-9
[29]. Extensive evidence has been accumulated demon-
strating that the mitochondrial outer membrane
permeabilization can be mediated via permeability transi-
tion pore (PTP) or via Bcl-2 family proteins [30, 35, 36].
Our results suggest that peroxynitrite induces MOM per-
meabilization by increasing intracellular levels of Bax,
without affecting Bcl-2 intracellular levels. Bax is a pro-
apoptotic member of the Bcl-2 family that has been
implicated in MOM permeabilization, via formation of
proteic pores, lipidic pores or via interaction with pre-
existing mitochondrial pores, like PTP [30]. Moreover, Bax
cellular activity is antagonized through the formation of
heterodimmers with anti-apoptotic proteins, more specifi-
cally with Bcl-2. In this way, the ratio Bax/Bcl-2
determines the fate of the cell survival and cell death type.
The role of PTP in MOM permeabilization, and the
subsequent peroxynitrite-elicited caspase-9 activation in
endothelial cells, has not been totally clarified. PTP open-
ing is associated with mitochondrial membrane potential
dissipation, mitochondrial swelling and MOM rupture [35,
36]. In our model and in agreement with several other
reports, peroxynitrite induced a rapid and significant
decrease in the mitochondrial membrane potential [37–40],
which can be ascribed to PTP and consequently to the
mitochondrial permeability transition event. In fact, per-
oxynitrite has been largely described as a mitochondrial
permeability transition (MPT) inducer in isolated mito-
chondria, an effect that has been associated to peroxynitrite
ability to oxidize Cys residue thiol groups of adenine
nucleotide translocase (ANT), one of the PTP constituents
[41]. However, the dissipation of the mitochondrial mem-
brane potential can also be the result of either the
respiratory chain inhibition, considering that several chain
components are inhibited by peroxynitrite or a conse-
quence of a severe energetic depletion [37, 42, 43].
Additionally, in the last few years, MPT has been observed
during the onset of necrosis and therefore appears to be a
non-exclusive process of apoptosis [44].
On the other hand, the absence of resveratrol effects on
the decrease in peroxynitrite-elicited mitochondrial mem-
brane potential, strengthens the idea that the mitochondrial
membrane potential dissipation is better related to necrosis
than to apoptosis. Thus, it is reasonable to consider that in
our experimental settings mitochondrial membrane poten-
tial dissipation observed is the sum of different effects of
peroxynitrite, with different consequences in mitochondria.
Although the concentration of peroxynitrite used in this
work seems to be relatively high, the net exposure of cells
to peroxynitrite is much lower than 500 lM as it has a half
life less than 1 s at 37C, pH 7.4 [45]. Moreover, in vivo
peroxynitrite formation has been estimated to be as high as
50–100 lM to 1 mM [46].
The increase in Bcl-2 levels can be an important
mechanism whereby resveratrol protects cells from per-
oxynitrite-triggered apoptosis. In other studies, Bcl-2
overexpression has been shown to prevent apoptosis but
not necrosis elicited by peroxynitrite [37, 40, 41]. Indeed,
while Bcl-2 inhibits, e.g., caspases activation induced by
peroxynitrite, it has no effect on mitochondrial membrane
potential dissipation associated to non-passive necrosis
[37]. So, resveratrol, in a similar way to Bcl-2, and prob-
ably by raising Bcl-2 intracellular levels, probably protects
cells from apoptosis but not from necrosis triggered by
peroxynitrite.
The mechanisms underlying resveratrol ability to mod-
ulate Bcl-2 intracellular levels in endothelial cells are
unclear. At least two possible mechanisms, that can act
concurrently, may account for this resveratrol effect: one,
based on its antioxidant properties that influence cellular
redox state and consequently cellular signaling pathways
and redox-sensitive transcription factors; another, based on
its non-antioxidant properties. We presume that the pref-
erential mechanism by which resveratrol modulates Bcl-2
cellular levels will vary with its concentration. Indeed,
resveratrol, at the highest concentration tested in this study,
not only exhibits a higher capacity to scavenge free radicals
but also improves the redox cellular state, by increasing
enzymatic and non-enzymatic antioxidant cellular system,
such as SOD, catalase, glutathione redutase and more
specifically GSH in BAEC [14, 47]. Thus, it is more likely
that in our experimental model, 50 lM resveratrol modu-
lates Bcl-2 levels by affecting the redox cellular state,
whereas 10 lM resveratrol has not a significant role on that
state and consequently on the redox-sensitive mechanisms.
Actually, it has been recently reported that pharmacologi-
cal preconditioning of rat hearts with 10 lM resveratrol
increases Bcl-2 levels through adenosine A1 and A3
receptors activation, the former transmitting a survival
signal through PI3K-Akt-Bcl-2 signaling pathway and the
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latter through CREB-dependent Bcl-2 pathway in addition
to an Akt-Bcl-2 pathway [48]. Also, it has been shown that
resveratrol modulates estrogen receptor-a-associated PI3K
activity in a biphasic way, inducing activation at 10 lM
and inactivation at higher concentrations [49]. The mech-
anism by which resveratrol modulates Bcl-2 cellular levels
will need to be investigated in more details in future work.
While most data in the literature support a pro-apoptotic
role for resveratrol, several studies report anti-apoptotic
actions as observed in this work [50–53]. Although the
reason for these discrepancies is not completely clear, both
resveratrol concentration and cell type used may be rele-
vant factors. Concerning cell type, resveratrol effects on
cell proliferation and viability appears to be dependent on
the cellular growth rates, i.e., the higher the proliferation
rate the higher the sensitivity to resveratrol toxic effects.
This idea is supported by the observation that freshly iso-
lated normal human cells, with low passage number, are
less sensitive to the pro-apoptotic effects of resveratrol than
immortalized malignant or not malignant cell lines char-
acterized by higher growth rates [54, 55]. It has been
suggested that DNA synthesis could be the link between
growth rates and cell sensitivity to resveratrol due to its
ability to inhibit crucial enzymes involved in DNA syn-
thesis, namely ribonucleotide reductase and DNA
polymerase [56, 57].
In summary, this study confirms a biochemical apoptotic
pathway for peroxynitrite-triggered endothelial cell death
and expands our knowledge about the cellular mechanism
implicated in resveratrol cytoprotective activities. Our
results showed that resveratrol, at concentrations so low as
10 lM, inhibited biochemical and cellular mechanisms
underlying apoptosis elicited by peroxynitrite and that
resveratrol preferentially disrupted the mitochondrial
apoptotic pathway than the death receptor apoptotic path-
way, through modulation of Bcl-2 intracellular levels,
considerably decreasing the Bax/Bcl-2 ratio. Furthermore,
this study highlights the idea that resveratrol cardiopro-
tective effects go far beyond its direct antioxidant activity
and that its cellular signaling and molecular effects have a
putative role to play.
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